These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 67561)

  • 1. Recent studies on the assessment of cell-mediated cytotoxicity in vitro.
    Weiss DW
    Natl Cancer Inst Monogr; 1976 Nov; 44():141. PubMed ID: 67561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 6. Embryonic antigens in tumor immunity.
    Della Porta G
    Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens.
    Kall MA; Hellström I
    J Immunol; 1975 Mar; 114(3):1083-8. PubMed ID: 1112984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune selection of tumor cell variants in chickens bearing tumors induced by avian sarcoma virus.
    Wainberg MA; Israel E; Yu M
    Cancer Res; 1982 May; 42(5):1669-75. PubMed ID: 6279281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro.
    Wainberg MA; Markson Y; Weiss DW; Doljanski F
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3565-9. PubMed ID: 4139718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL; Remington JS
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH; Anderson AB
    Cancer Res; 1988 Mar; 48(6):1398-403. PubMed ID: 3257896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
    Shiku H; Bean MA; Old LJ; Oettgen HF
    J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.
    Boyer PJ; Fahey JL
    J Immunol; 1976 Jan; 116(1):202-9. PubMed ID: 128571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.